Anomalous response to potassium in vascular smooth muscle cells of human saphenous vein
Relaxant responses to calcium channel antagonists and potassium channel opener in human saphenous vein
Oral treatment and in vitro incubation with fructose modify vascular prostanoid production in the rat
Captopril therapy decreases both expression and function of α1D-adrenoceptors in pre-hypertensive rat aorta
Visceral related cortical areas : L1
Optical recording of synaptic events in simple nervous systems : L2
Histamine as a neurotransmitter in the central nervous system : L3
The involvement of nitric oxide in the responses of ruminant blood vessels to neurotransmitters and other vasoactive agents : L4
Pharmacological treatment of cognitive impairments in Alzheimer's disease : L5
The role of brain cholinesterases and their inhibition in treatment of Alzheimer's disease : L6
Matrix metalloproteinase-9 – a novel retrograde synaptic messenger? : L7
Vasoactive intestinal peptide – a VIP protective peptide : L8
The purinergic mechano-sensory transduction : L9
Cerebrocrast, a cognition enhancer and neuroprotectant : focus on mitochondrial functions
Peripheral effects of opioids and cannabinoids : studies on sensory neurones and fibres
Central and peripheral pathways activated by Ghrelin and involved in the regulation of gastrointestinal function. : L12
Ascending and descending enteric reflexes – regional functional coordination and efficacy : L13
Can cyclosporin A (CsA) – dependent down regulation of the Na+-Ca2+ exchanger provide an explanation for the drug related clinical complications?* : L14
Regulation of transmitter release : L15
Regulation of neurotransmitter release by presynaptic P2X receptors : L16
New group of indole-derived neuroprotective drugs interacting with oxidative stress : L17
Genes, gender and neurotransmission in opioid analgesia and addiction : L18
Pesticides, xenobiotic metabolism and neurodegenerative brain diseases : L19
In vivo effects of alloxan on lipid peroxidation, protein oxidation, proteasome and antioxidant enzyme activities in liver and kidney of copper- and iron-loaded rats : P1
Ubiquitin-proteasome pathway – a primary mechanism for the regulated turnover of synaptic proteins proteasome inhibition : P2
Chromatographic analysis of dopamine metabolism in a Parkinsonian model : P3
Effects of alpha2-adrenergic receptors on membrane potential and calcium dynamics of layer 5 pyramidal cells : P4
Analgesic effects of some newly synthesized pyrrole derivates in rats : P5
Anti-inflammatory effects of some newly synthesized pyrrole derivates in rats : P6
The ability of PACAP, VIP and PHI to stimulate cAMP formation in cultured primary glial cells and C6 glioma cells : P7
In vitro ischaemia models evoked parallel intracellular sodium and calcium dynamics in CA1 pyramidal cells : P8
Effects of the metabotropic glutamate receptor subtype 5 (MGluRs5) blockade on inhibitory avoidance in rats : P9
Dual modulation of [3H]-noradrenaline release from the spinal cord by P2 purine receptors : P10
Modelling drug effects on sodium channels : P11
Cannabinoids : effects on lipid peroxidation and antioxidant defence systems in brain and stomach of rats
Role of neurofilaments in expression of NMDA, dopamine D1, and nACh α7 receptors : P13
Effects of purified saponins' mixture, isolated from Astragalus corniculatus, on dopamine model of oxidative stress in synaptosomes : P14
Effect of vasoactiven intestinal peptide (VIP) on catecholamine release in rat hippocampus : in vivo microdialysis study
Effects of some neuroactive steroids and neuropeptides on hydrogen peroxide-induced toxicity in SH-SY5Y cells : P16
The inverse relationship between dopamine and melatonin in the Turkey retina : P17
Gastric-related amygdalofugal pathways : P18
Mild oxidative stress combined with mitochondrial dysfunction may cause neurodegeneration : involvement of monoamines
Free radical-induced contractility disturbances in a guinea-pig ileum in vitro model : P20
Electroencephalographic monitoring after treatment with the N-methyl-D-aspartate receptor antagonist MK 801 in the endothelin-1 model of focal cerebral ischaemia in rats : P21
The mechanisms underlying different components of paired-pulse facilitation at the frog neuromuscular junction : P22
Enkephalin-induced adhesion : role of thermotropic properties of the lipid bilayer
Lack of ATP-evoked GABA and glutamate release in the hippocampus of P2X7 receptor −/− mice : P24
Effects of angiotensinergic agents on the circadian fluctuations of the pain threshold in rats : P25
Mildronate, cerebrocrast, and glutapyrone as highly active cardioprotectors in the AZT-induced cardiomyopathy in mice : P26
Comparative studies of cerebrocrast, glutapyrone and mildronate in AZT-induced neurotoxicity in mice : P27
Analysis of specificity of antibodies produced against synthetic fragments of different neuronal nicotinic acetylcholine receptor subtypes : P28
Muscarinic modulation of nitrergic and noradrenergic neurotransmissions in visceral smooth muscles : P29
Effect of calcium antagonist diltiazem on the anticonvulsants withdrawal syndrome : P30
Nicotine-induced bidirectional effects in spines of hippocampal pyramidal neurones : P31
Anxiogenic effect of vasoactive intestinal peptide microinjected into the rat cal hippocampal area : P32
Hippocampal vasoactive intestinal peptide involved in the rats exploratory behavior : P33
Brainstem projections to the amygdala in the rat. retrograde tracing study : P34
Kainate receptors in the turtle retina : an immunocytochemical study
Behavioral and biochemical changes in rats after multiple administration of morphine alone and in combination with nifedipine : P36
Effect of 2.45 GHz electromagnetic field on acetylcholinesterase activity in frog skeletal muscle : P37
Effects of a CB1/CB2 agonist on spasmogen-induced smooth-muscle contractions : P38
A study on the potential of isoteoline to induce tolerance to its anxiolytic effect and withdrawal anxiety after chronic treatment : P39